TRAF3 and Miyoshi myopathy: Primary MM patient samples and cell lines often show genetic or epigenetic alterations in the NF-κB signaling network, including NIK, TRAF3, CYLD, BIRC2, BIRC3, CD40, NFKB1 or NFKB2 [4,5].